Rapid Remission of Sunburn-Induced Guttate Psoriasis with Guselkumab
Abstract Guselkumab is an anti-interleukin-23 monoclonal antibody that is approved for plaque psoriasis and psoriatic arthritis. We present a case of a 28-year-old female patient with acute onset of guttate psoriasis after a blistering sunburn. She had no personal or family history of psoriasis or c...
Saved in:
Main Authors: | Erin Bartholomew (Author), Bo-Young Chung (Author), Mitchell Davis (Author), Samuel Yeroushalmi (Author), Mimi Chung (Author), Marwa Hakimi (Author), Tina Bhutani (Author), Wilson Liao (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparing the odds of reported depression in psoriasis patients on systemic therapy: a cross-sectional analysis of postmarketing data
by: Samuel Yeroushalmi, et al.
Published: (2023) -
Psoriasis and Exercise: A Review
by: Yeroushalmi S, et al.
Published: (2022) -
Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives
by: Chung M, et al.
Published: (2022) -
Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series
by: Grace C. Brummer, BS, et al.
Published: (2017) -
Examining worldwide postmarketing suicides from biologics used for psoriasis with a focus on brodalumab: A cross-sectional analysis using the Food and Drug Administration Adverse Event Reporting System (FAERS)
by: Samuel Yeroushalmi, BS, et al.
Published: (2022)